Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve.
Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve.
复制标题
DOI:
10.1038/ncomms15481
复制
发表时间:
2017-05-25
影响因子:
16.6
通讯作者:
Willer CJ
中科院分区:
文献类型:
--
作者:
Yang B;Zhou W;Jiao J;Nielsen JB;Mathis MR;Heydarpour M;Lettre G;Folkersen L;Prakash S;Schurmann C;Fritsche L;Farnum GA;Lin M;Othman M;Hornsby W;Driscoll A;Levasseur A;Thomas M;Farhat L;Dubé MP;Isselbacher EM;Franco-Cereceda A;Guo DC;Bottinger EP;Deeb GM;Booher A;Kheterpal S;Chen YE;Kang HM;Kitzman J;Cordell HJ;Keavney BD;Goodship JA;Ganesh SK;Abecasis G;Eagle KA;Boyle AP;Loos RJF;Eriksson P;Tardif JC;Brummett CM;Milewicz DM;Body SC;Willer CJ
Bicuspid aortic valve (BAV) is a heritable congenital heart defect and an important risk factor for valvulopathy and aortopathy. Here we report a genome-wide association scan of 466 BAV cases and 4,660 age, sex and ethnicity-matched controls with replication in up to 1,326 cases and 8,103 controls. We identify association with a noncoding variant 151 kb from the gene encoding the cardiac-specific transcription factor, GATA4, and near-significance for p.Ser377Gly in GATA4. GATA4 was interrupted by CRISPR-Cas9 in induced pluripotent stem cells from healthy donors. The disruption of GATA4 significantly impaired the transition from endothelial cells into mesenchymal cells, a critical step in heart valve development. Bicuspid aortic valve (BAV) is the most common human congenital cardiovascular malformation. Here, the authors perform a genome-wide association study for BAV and identify risk variants in the gene region of cardiac-specific transcription factor GATA4 and implicate GATA4 in heart valve development.